A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma
Название протокола
Клинические исследование Multiple Myeloma: Daratumumab, Pomalidomide, Dexamethasone, Bortezomib, Teclistamab - Реестр клинических исследований
